{"id":"https://openalex.org/W2945644530","doi":"https://doi.org/10.1098/rsos.190366","title":"In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model","display_name":"In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model","publication_year":2019,"publication_date":"2019-05-01","ids":{"openalex":"https://openalex.org/W2945644530","doi":"https://doi.org/10.1098/rsos.190366","mag":"2945644530","pmid":"https://pubmed.ncbi.nlm.nih.gov/31218069","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6549962"},"language":"en","primary_location":{"id":"doi:10.1098/rsos.190366","doi":"https://doi.org/10.1098/rsos.190366","is_oa":true,"landing_page_url":"https://doi.org/10.1098/rsos.190366","pdf_url":null,"source":{"id":"https://openalex.org/S2737558550","display_name":"Royal Society Open Science","issn_l":"2054-5703","issn":["2054-5703"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319787","host_organization_name":"Royal Society","host_organization_lineage":["https://openalex.org/P4310319787"],"host_organization_lineage_names":["Royal Society"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Royal Society Open Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1098/rsos.190366","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100699170","display_name":"Hanwen Wang","orcid":"https://orcid.org/0000-0001-5480-431X","observed_orcids":["https://orcid.org/0000-0001-5480-431X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hanwen Wang","raw_affiliation_strings":["Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA"],"raw_orcid":"https://orcid.org/0000-0001-5480-431X","affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015640240","display_name":"Oleg Milberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oleg Milberg","raw_affiliation_strings":["Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967121","display_name":"Imke Heleen Bartelink","orcid":"https://orcid.org/0000-0001-9602-3407","observed_orcids":["https://orcid.org/0000-0001-9602-3407"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL","US"],"is_corresponding":false,"raw_author_name":"Imke H. Bartelink","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and DMPK (CPD), MedImmune, South San Francisco, CA, USA","Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands","Department of Medicine, University of California, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and DMPK (CPD), MedImmune, South San Francisco, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I865915315"]},{"raw_affiliation_string":"Department of Medicine, University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103510991","display_name":"Paolo Vicini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paolo Vicini","raw_affiliation_strings":["Clinical Pharmacology, Pharmacometrics and DMPK, MedImmune, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmacometrics and DMPK, MedImmune, Cambridge, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100382530","display_name":"Bing Wang","orcid":"https://orcid.org/0000-0002-9038-9878","observed_orcids":["https://orcid.org/0000-0002-9038-9878"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bing Wang","raw_affiliation_strings":["Amador Bioscience Inc, Pleasanton, CA 94588, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amador Bioscience Inc, Pleasanton, CA 94588, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110048076","display_name":"Rajesh Narwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajesh Narwal","raw_affiliation_strings":["Clinical Pharmacology and DMPK (CPD), MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology and DMPK (CPD), MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069627913","display_name":"Lorin K. Roskos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorin Roskos","raw_affiliation_strings":["Clinical Pharmacology and DMPK (CPD), MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology and DMPK (CPD), MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036750199","display_name":"Cesar Augusto Santa-Maria","orcid":"https://orcid.org/0000-0003-0979-8787","observed_orcids":["https://orcid.org/0000-0003-0979-8787"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cesar A. Santa-Maria","raw_affiliation_strings":["Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030268482","display_name":"Aleksander S. Popel","orcid":"https://orcid.org/0000-0002-6706-9235","observed_orcids":["https://orcid.org/0000-0002-6706-9235"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aleksander S. Popel","raw_affiliation_strings":["Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA","Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5100699170"],"corresponding_institution_ids":["https://openalex.org/I145311948"],"apc_list":{"value":1200,"currency":"GBP","value_usd":1471},"apc_paid":{"value":1200,"currency":"GBP","value_usd":1471},"fwci":4.2685,"has_fulltext":true,"cited_by_count":62,"citation_normalized_percentile":{"value":0.95835796,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"6","issue":"5","first_page":"190366","last_page":"190366"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.039400000125169754,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8339999914169312},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8960000276565552},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.9559999704360962},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/quantitative-systems-pharmacology","display_name":"quantitative systems pharmacology","score":0.7770000100135803},{"id":"https://openalex.org/keywords/tumor-draining-lymph-nodes","display_name":"tumor-draining lymph nodes","score":0.8399999737739563},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9670000076293945},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.8149999976158142},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8040000200271606},{"id":"https://openalex.org/keywords/tumor-response-prediction","display_name":"tumor response prediction","score":0.7609999775886536},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.8109999895095825},{"id":"https://openalex.org/keywords/tumor-burden","display_name":"tumor burden","score":0.7480000257492065},{"id":"https://openalex.org/keywords/personalized-immunotherapy","display_name":"personalized immunotherapy","score":0.6890000104904175},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6499999761581421}],"concepts":[{"id":"https://openalex.org/C2779446555","wikidata":"https://www.wikidata.org/wiki/Q7663877","display_name":"Systems pharmacology","level":3,"score":0.7212424278259277},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.7169700860977173},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5773715376853943},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5268536806106567},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5262552499771118},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.5208361744880676},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4833192825317383},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4816802442073822},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4159797430038452},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4100882411003113},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40254074335098267},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3688163161277771},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29659634828567505},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2865327000617981},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2805282175540924},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2416718304157257},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.19209718704223633},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.12610352039337158},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08527520298957825},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.1098/rsos.190366","doi":"https://doi.org/10.1098/rsos.190366","is_oa":true,"landing_page_url":"https://doi.org/10.1098/rsos.190366","pdf_url":null,"source":{"id":"https://openalex.org/S2737558550","display_name":"Royal Society Open Science","issn_l":"2054-5703","issn":["2054-5703"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319787","host_organization_name":"Royal Society","host_organization_lineage":["https://openalex.org/P4310319787"],"host_organization_lineage_names":["Royal Society"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Royal Society Open Science","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6549962","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6549962","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"R Soc Open Sci","raw_type":"Text"},{"id":"pmid:31218069","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31218069","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Royal Society open science","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/185e5ade-e478-4e84-8aab-31751164f071","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/files/157481369/In-silico-simulation-of-a-clinical-trial-with-anti-ctla-4-and-anti-pd-l1-immunotherapies-in-metastatic-breast-cancer-usi.pdf","pdf_url":"https://pure.amsterdamumc.nl/ws/files/157481369/In-silico-simulation-of-a-clinical-trial-with-anti-ctla-4-and-anti-pd-l1-immunotherapies-in-metastatic-breast-cancer-usi.pdf","source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Wang, H, Milberg, O, Bartelink, I H, Vicini, P, Wang, B, Narwal, R, Roskos, L, Santa-Maria, C A & Popel, A S 2019, 'In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model', Royal Society open science, vol. 6, no. 5, 190366. https://doi.org/10.1098/rsos.190366","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:572016b0fdc645a1b9f505b6ab696d63","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/572016b0fdc645a1b9f505b6ab696d63","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Royal Society Open Science, Vol 6, Iss 5 (2019)","raw_type":"article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/b4987253-88ba-4c08-95b4-54ec379726d4","doi":null,"is_oa":true,"landing_page_url":"https://research.vumc.nl/en/publications/b4987253-88ba-4c08-95b4-54ec379726d4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Royal Society Open Science, 6(5):190366. The Royal Society","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1098/rsos.190366","doi":"https://doi.org/10.1098/rsos.190366","is_oa":true,"landing_page_url":"https://doi.org/10.1098/rsos.190366","pdf_url":null,"source":{"id":"https://openalex.org/S2737558550","display_name":"Royal Society Open Science","issn_l":"2054-5703","issn":["2054-5703"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319787","host_organization_name":"Royal Society","host_organization_lineage":["https://openalex.org/P4310319787"],"host_organization_lineage_names":["Royal Society"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Royal Society Open Science","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6748116565","display_name":"Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer","funder_award_id":"R01CA138264","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320322783","display_name":"MedImmune","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2945644530.pdf","grobid_xml":"https://content.openalex.org/works/W2945644530.grobid-xml"},"referenced_works_count":70,"referenced_works":["https://openalex.org/W1536396613","https://openalex.org/W1661544713","https://openalex.org/W1791759367","https://openalex.org/W1889335134","https://openalex.org/W1980628210","https://openalex.org/W1991164000","https://openalex.org/W2004150448","https://openalex.org/W2007150539","https://openalex.org/W2015776459","https://openalex.org/W2019607817","https://openalex.org/W2024203129","https://openalex.org/W2026767467","https://openalex.org/W2044311845","https://openalex.org/W2049553585","https://openalex.org/W2057187391","https://openalex.org/W2068868056","https://openalex.org/W2071069178","https://openalex.org/W2083210466","https://openalex.org/W2094366129","https://openalex.org/W2097200850","https://openalex.org/W2097855813","https://openalex.org/W2102439908","https://openalex.org/W2107380545","https://openalex.org/W2123176392","https://openalex.org/W2133842044","https://openalex.org/W2135747342","https://openalex.org/W2143459396","https://openalex.org/W2147763277","https://openalex.org/W2152803686","https://openalex.org/W2158253095","https://openalex.org/W2172170289","https://openalex.org/W2335914738","https://openalex.org/W2403668839","https://openalex.org/W2560367415","https://openalex.org/W2582822937","https://openalex.org/W2591958823","https://openalex.org/W2603528121","https://openalex.org/W2605630275","https://openalex.org/W2606240373","https://openalex.org/W2610302377","https://openalex.org/W2613553789","https://openalex.org/W2614702762","https://openalex.org/W2616581328","https://openalex.org/W2619891302","https://openalex.org/W2619951286","https://openalex.org/W2621280624","https://openalex.org/W2621587943","https://openalex.org/W2744067212","https://openalex.org/W2753939078","https://openalex.org/W2757241773","https://openalex.org/W2758791715","https://openalex.org/W2766581433","https://openalex.org/W2771328375","https://openalex.org/W2772859838","https://openalex.org/W2775344839","https://openalex.org/W2779221466","https://openalex.org/W2781525129","https://openalex.org/W2783246934","https://openalex.org/W2784151151","https://openalex.org/W2794762714","https://openalex.org/W2798022026","https://openalex.org/W2806758957","https://openalex.org/W2834875999","https://openalex.org/W2889746019","https://openalex.org/W2896799864","https://openalex.org/W2897422388","https://openalex.org/W2903072518","https://openalex.org/W2905499108","https://openalex.org/W2910271149","https://openalex.org/W2924122631"],"related_works":["https://openalex.org/W3007686018","https://openalex.org/W4394826215","https://openalex.org/W2740540975","https://openalex.org/W3126910508","https://openalex.org/W6920825573","https://openalex.org/W7212161602","https://openalex.org/W7129593665","https://openalex.org/W2753939078","https://openalex.org/W4400243027","https://openalex.org/W3008411263"],"abstract_inverted_index":{"The":[0,66,129,168],"low":[1],"response":[2,90,102,140],"rate":[3],"of":[4,24,138,141,160,193],"immune":[5,71,124],"checkpoint":[6,84,92,104],"blockade":[7,93,105],"in":[8,51,75],"breast":[9,54,194],"cancer":[10,195],"has":[11],"highlighted":[12],"the":[13,70,79,88,97,100,123,133],"need":[14],"for":[15],"predictive":[16],"biomarkers":[17],"to":[18,46,83,91,103,135,157,180,191],"identify":[19],"responders.":[20],"While":[21],"a":[22,39,150],"number":[23],"clinical":[25,146],"trials":[26],"are":[27],"ongoing,":[28],"testing":[29],"all":[30],"possible":[31],"combinations":[32],"is":[33,44],"not":[34],"feasible.":[35],"In":[36],"this":[37,173],"study,":[38],"quantitative":[40],"systems":[41,174],"pharmacology":[42,175],"model":[43,67,131,176],"built":[45],"integrate":[47],"immune-cancer":[48],"cell":[49],"interactions":[50],"patients":[52,143],"with":[53,165],"cancer,":[55],"including":[56,116],"central,":[57],"peripheral,":[58],"tumour-draining":[59],"lymph":[60],"node":[61],"(TDLN)":[62],"and":[63,73,78,86,107,113,119,148,162],"tumour":[64,80,89,101,109,139],"compartments.":[65],"can":[68,153,177],"describe":[69],"suppression":[72],"evasion":[74],"both":[76],"TDLN":[77],"microenvironment":[81],"due":[82],"expression,":[85],"mimic":[87],"therapy.":[94],"We":[95],"investigate":[96],"relationship":[98],"between":[99],"therapy":[106],"composite":[108],"burden,":[110],"PD-L1":[111],"expression":[112],"antigen":[114],"intensity,":[115],"their":[117,163],"individual":[118,142],"combined":[120],"effects":[121],"on":[122],"system,":[125],"using":[126],"model-based":[127],"simulations.":[128],"proposed":[130],"demonstrates":[132],"potential":[134],"make":[136],"predictions":[137,170],"given":[144],"sufficient":[145],"measurements,":[147],"provides":[149],"platform":[151],"that":[152],"be":[154,178],"further":[155],"adapted":[156],"other":[158],"types":[159],"immunotherapy":[161,182],"combination":[164],"molecular-targeted":[166],"therapies.":[167],"patient":[169],"demonstrate":[171],"how":[172],"used":[179],"individualize":[181],"treatments.":[183],"When":[184],"appropriately":[185],"validated,":[186],"these":[187],"approaches":[188],"may":[189],"contribute":[190],"optimization":[192],"treatment.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-05-29T00:00:00"}